{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:51:02Z","timestamp":1791021062024,"version":"4.1.0"},"reference-count":89,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>For decades, lipids were confined to the field of structural biology and energetics as they were considered only structural constituents of cellular membranes and efficient sources of energy production. However, with advances in our understanding in lipidomics and improvements in the technological approaches, astounding discoveries have been made in exploring the role of lipids as signaling molecules, termed bioactive lipids. Among these bioactive lipids, sphingolipids have emerged as distinctive mediators of various cellular processes, ranging from cell growth and proliferation to cellular apoptosis, executing immune responses to regulating inflammation. Recent studies have made it clear that sphingolipids, their metabolic intermediates (ceramide, sphingosine-1-phosphate, and N-acetyl sphingosine), and enzyme systems (cyclooxygenases, sphingosine kinases, and sphingomyelinase) harbor diverse yet interconnected signaling pathways in the central nervous system (CNS), orchestrate CNS physiological processes, and participate in a plethora of neuroinflammatory and neurodegenerative disorders. Considering the unequivocal importance of sphingolipids in CNS, we review the recent discoveries detailing the major enzymes involved in sphingolipid metabolism (particularly sphingosine kinase 1), novel metabolic intermediates (N-acetyl sphingosine), and their complex interactions in CNS physiology, disruption of their functionality in neurodegenerative disorders, and therapeutic strategies targeting sphingolipids for improved drug approaches.<\/jats:p>","DOI":"10.3390\/ijms22147353","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T10:42:17Z","timestamp":1625740937000},"page":"7353","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration"],"prefix":"10.3390","volume":"22","author":[{"given":"Maria","family":"Ayub","sequence":"first","affiliation":[{"name":"KNU Alzheimer\u2019s Disease Research Institute, Kyungpook National University, Daegu 41566, Korea"},{"name":"Department of Physiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Kyung","family":"Jin","sequence":"additional","affiliation":[{"name":"KNU Alzheimer\u2019s Disease Research Institute, Kyungpook National University, Daegu 41566, Korea"},{"name":"Department of Laboratory Animal Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-sung","family":"Bae","sequence":"additional","affiliation":[{"name":"KNU Alzheimer\u2019s Disease Research Institute, Kyungpook National University, Daegu 41566, Korea"},{"name":"Department of Physiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrm2934","article-title":"Lipidomics: Coming to grips with lipid diversity","volume":"11","author":"Shevchenko","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bari, M., and Bisogno, T. (2020). Bioactive Lipids in Health and Disease. Biomolecules, 10.","DOI":"10.3390\/biom10121698"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, X., Wu, D., and Shen, H. (2018). Phospholipid and Phospholipidomics in Health and Diseases. Lipidomics in Health & Disease: Methods & Application, Springer.","DOI":"10.1007\/978-981-13-0620-4"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kleuser, B. (2018). The Enigma of Sphingolipids in Health and Disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103126"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Bifulco","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","article-title":"Role of cholesterol and sphingolipids in brain development and neurological diseases","volume":"18","author":"Hussain","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","article-title":"Lipid mediators in health and disease: Enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation","volume":"49","author":"Shimizu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_10","first-page":"333","article-title":"Eicosanoids: Essential mediators in health and disease\/Eicosanoide: Bedeutende Faktoren in der Hom\u00f6ostase und ihre Bedeutung in der Pathogenese multipler Erkrankungen","volume":"33","author":"Bruegel","year":"2009","journal-title":"Lab. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1042\/CS20191209","article-title":"Eicosanoid blood vessel regulation in physiological and pathological states","volume":"134","author":"Imig","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_12","first-page":"220","article-title":"The role of eicosanoids in the brain","volume":"17","author":"Tassoni","year":"2008","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.placenta.2016.12.013","article-title":"Review: Eicosanoids in preterm labor and delivery: Potential roles of exosomes in eicosanoid functions","volume":"54","author":"Peiris","year":"2017","journal-title":"Placenta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1139\/o80-147","article-title":"Phospholipids and membrane transport","volume":"58","author":"Cullis","year":"1980","journal-title":"Can. J. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.00002.2012","article-title":"Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis","volume":"93","author":"Bohdanowicz","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1172\/JCI97944","article-title":"Phospholipid signaling in innate immune cells","volume":"128","author":"Rossjohn","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Morales, V., Montero, F., Gonz\u00e1lez-Forero, D., Rodr\u00edguez-Bey, G., G\u00f3mez-P\u00e9rez, L., Medialdea-Wandossell, M.J., Dom\u00ednguez-V\u00edas, G., Garc\u00eda-Verdugo, J.M., and Moreno-L\u00f3pez, B. (2015). Membrane-derived phospholipids control synaptic neurotransmission and plasticity. PLoS Biol., 13.","DOI":"10.1371\/journal.pbio.1002153"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lajtha, A., Tettamanti, G., and Goracci, G. (2009). Brain Oxidative Stress from a Phospholipid Perspective. Handbook of Neurochemistry and Molecular Neurobiology: Neural Lipids, Springer.","DOI":"10.1007\/978-0-387-30378-9"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tibs.2010.08.001","article-title":"Regulation of sphingosine kinase and sphingolipid signaling","volume":"36","author":"Pitson","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: Lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"ref_23","first-page":"181","article-title":"Lipoxins: Nature\u2019s way to resolve inflammation","volume":"8","author":"Chandrasekharan","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: Emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fphar.2018.01582","article-title":"The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes","volume":"9","author":"Hansen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2380319","DOI":"10.1155\/2018\/2380319","article-title":"Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases","volume":"2018","author":"Tang","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/EBC20190082","article-title":"Oxidation of polyunsaturated fatty acids to produce lipid mediators","volume":"64","author":"Christie","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_28","unstructured":"Vance, D.E., and Vance, J.E. (2008). CHAPTER 12\u2014The Eicosanoids: Cyclooxygenase, Lipoxygenase, and Epoxygenase Pathways. Biochemistry of Lipids, Lipoproteins and Membranes, Elsevier. [5th ed.]."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: Structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/iub.337","article-title":"The Kennedy pathway\u2014De novo synthesis of phosphatidylethanolamine and phosphatidylcholine","volume":"62","author":"Gibellini","year":"2010","journal-title":"IUBMB Life"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","article-title":"Chapter Two\u2014Phosphatidylethanolamine Metabolism in Health and Disease","volume":"Volume 321","author":"Jeon","year":"2016","journal-title":"International Review of Cell and Molecular Biology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.devcel.2011.10.016","article-title":"Phosphatidylinositol synthase and diacylglycerol platforms bust a move","volume":"21","author":"Bankaitis","year":"2011","journal-title":"Dev. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: From synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","first-page":"3393","article-title":"Biosynthesis of proresolving lipid mediators by vascular cells and tissues","volume":"31","author":"Chatterjee","year":"2017","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_35","first-page":"473","article-title":"Prostaglandins and inflammation: The cyclooxygenase controversy","volume":"48","author":"Morteau","year":"2000","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5483\/BMBRep.2020.53.1.278","article-title":"Sphingolipids in neuroinflammation: A potential target for diagnosis and therapy","volume":"53","author":"Lee","year":"2020","journal-title":"BMB Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.2174\/0929867324666170216113756","article-title":"Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases","volume":"25","author":"Russo","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1471-4159.2009.06038.x","article-title":"Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors","volume":"109","author":"Wheeler","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/jnr.22438","article-title":"Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice","volume":"88","author":"Tabatadze","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","article-title":"Ceramide function in the brain: When a slight tilt is enough","volume":"70","author":"Mencarelli","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1044-7431(02)00028-3","article-title":"Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway","volume":"22","author":"Stoica","year":"2003","journal-title":"Mol. Cell Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0006-291X(02)02593-7","article-title":"Ceramide induces neuronal apoptosis through the caspase-9\/caspase-3 pathway","volume":"299","author":"Movsesyan","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-019-1436-1","article-title":"Astrocytic ceramide as possible indicator of neuroinflammation","volume":"16","author":"Rozemuller","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer\u2019s and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_46","first-page":"346783","article-title":"Ceramides in Alzheimer\u2019s Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and A\u03b2 Accumulation","volume":"2015","author":"Hof","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","article-title":"Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease?","volume":"32","author":"Katsel","year":"2007","journal-title":"Neurochem. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","article-title":"Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems","volume":"17","author":"Healy","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.1618659114","article-title":"Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1","volume":"114","author":"Yanagida","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neuroscience.2010.10.021","article-title":"Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus","volume":"171","author":"Kanno","year":"2010","journal-title":"Neuroscience"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1523\/JNEUROSCI.3588-15.2016","article-title":"Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment","volume":"36","author":"Riganti","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cellsig.2008.07.011","article-title":"Sphingosine kinase\/sphingosine 1-phosphate signalling in central nervous system","volume":"21","author":"Okada","year":"2009","journal-title":"Cell. Signal."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Fischer, I., Alliod, C., Martinier, N., Newcombe, J., Brana, C., and Pouly, S. (2011). Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023905"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/hmg\/ddn126","article-title":"Sphingosine kinase 1\/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease","volume":"17","author":"Wu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41467-018-03674-2","article-title":"Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer\u2019s Disease","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2051-5960-2-9","article-title":"Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer\u2019s disease pathogenesis","volume":"2","author":"Couttas","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2051-5960-2-12","article-title":"Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer\u2019s disease","volume":"2","author":"Ceccom","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11064-014-1240-3","article-title":"Sphingosine kinases\/sphingosine-1-phosphate and death Signalling in APP-transfected cells","volume":"39","author":"Gassowska","year":"2014","journal-title":"Neurochem. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1101\/gad.188003.112","article-title":"Recruitment of sphingosine kinase to presynaptic terminals by a conserved muscarinic signaling pathway promotes neurotransmitter release","volume":"26","author":"Chan","year":"2012","journal-title":"Genes Dev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1083\/jcb.200402016","article-title":"Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension","volume":"166","author":"Toman","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1124\/mol.109.063115","article-title":"Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids","volume":"77","author":"Sharma","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fncel.2018.00169","article-title":"The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain","volume":"12","author":"Ronowska","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.ajpath.2013.01.051","article-title":"Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice","volume":"182","author":"Medeiros","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/cns.12069","article-title":"Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses","volume":"19","author":"Xu","year":"2013","journal-title":"CNS Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41467-020-16080-4","article-title":"N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer\u2019s disease","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mielke, M.M., Maetzler, W., Haughey, N.J., Bandaru, V.V., Savica, R., Deuschle, C., Gasser, T., Hauser, A.K., Gr\u00e4ber-Sultan, S., and Schleicher, E. (2013). Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: A pilot study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073094"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcmd.2016.11.007","article-title":"Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations","volume":"68","author":"Arkadir","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2016.10.039","article-title":"Oligomeric \u03b1-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson\u2019s disease","volume":"636","author":"Pchelina","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1074\/jbc.RA118.001986","article-title":"Extracellular \u03b1-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling","volume":"293","author":"Badawy","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5114\/fn.2014.45567","article-title":"The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson\u2019s disease","volume":"52","author":"Pyszko","year":"2014","journal-title":"Folia Neuropathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson\u2019s disease by activation of sphingosine kinase 1 and Akt kinase","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fnins.2017.00698","article-title":"De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington\u2019s Disease","volume":"11","author":"Basit","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/s41598-017-05709-y","article-title":"Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington\u2019s disease","volume":"7","author":"Amico","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Amico","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1073\/pnas.1508767112","article-title":"Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis","volume":"112","author":"Dodge","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fnmol.2017.00433","article-title":"Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis","volume":"10","author":"Henriques","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/EBC20190091","article-title":"Role of bioactive sphingolipids in physiology and pathology","volume":"64","author":"Presa","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fneur.2020.00437","article-title":"Exploring Sphingolipid Implications in Neurodegeneration","volume":"11","author":"Alessenko","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1212\/WNL.0000000000009277","article-title":"Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline","volume":"95","author":"Ryan","year":"2020","journal-title":"Neurology"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Grodzicki, W., and Dziendzikowska, K. (2020). The Role of Selected Bioactive Compounds in the Prevention of Alzheimer\u2019s Disease. Antioxidants, 9.","DOI":"10.3390\/antiox9030229"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.30574\/gscbps.2020.11.2.0143","article-title":"Functional foods and bioactive compounds: Roles in the prevention, treatment and management of neurodegenerative diseases","volume":"11","author":"John","year":"2020","journal-title":"GSC Biol. Pharm. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7353\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:27:54Z","timestamp":1760164074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":89,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147353"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147353","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]}}}